Post-Conference Perspectives: MOUNTAINEER Trials in GI Malignancies - Episode 2

HER2 as a Potential Drug Target and its Prevalence in GI Malignancies

An experienced oncologist discusses the role of HER2 in GI malignancies and the applicability of the existing body of research concerning HER2 in breast cancer.